← Celanese overview

Celanese vs Shin-Etsu Chemical Co.: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Celanese Corporation (CE)

Q3 2026
▲4

Celanese cuts debt, wins legal case, raises prices, adds robot demand

  • Debt reduction via Nutrinova stake sale Celanese is selling another 19% of its Nutrinova food-ingredients venture to Mitsui for about $152 million, cutting its stake to 11%. The cash goes toward paying down debt, part of a plan to raise $1 billion from asset sales by 2027. Lower debt makes the company safer and supports the stock.

    This is a major new step in Celanese's deleveraging plan, directly improving its financial health and reducing risk.

  • Legal claims dismissed in Amsterdam A Dutch court threw out all damages claims against Celanese from Shell and Repsol over past ethylene purchases. This removes a potential financial liability and simplifies the risk picture. With one less legal overhang, investors can focus on the business, which helps the stock.

    The court dismissal eliminates a significant legal risk that had been weighing on Celanese shares.

  • Price hikes on key acetyl products Celanese raised prices on four acetyl products, including acetic acid and vinyl acetate monomer, by up to $0.06 per pound in the US and Canada, with increases elsewhere. Higher prices can boost revenue and profit, especially after its Acetyl Chain sales jumped 28% in the second quarter. This supports the stock.

    The price increases show Celanese's ability to improve pricing, a direct positive for earnings and investor sentiment.

  • New demand from humanoid robot partnership Celanese teamed up with VIGOR Precision to supply high-performance plastics for humanoid robot joints, aiming to cut joint weight by over 30% versus metal. This opens a new market for Celanese's specialty materials, potentially adding future sales and showing growth beyond traditional chemicals.

    The partnership represents a new demand source and innovation, which could drive future revenue growth.

August 2026
▲4

Celanese cuts debt, wins legal case, raises prices, adds robot demand

  • Debt reduction via Nutrinova stake sale Celanese is selling another 19% of its Nutrinova food-ingredients venture to Mitsui for about $152 million, cutting its stake to 11%. The cash goes toward paying down debt, part of a plan to raise $1 billion from asset sales by 2027. Lower debt makes the company safer and supports the stock.

    This is a major new step in Celanese's deleveraging plan, directly improving its financial health and reducing risk.

  • Legal claims dismissed in Amsterdam A Dutch court threw out all damages claims against Celanese from Shell and Repsol over past ethylene purchases. This removes a potential financial liability and simplifies the risk picture. With one less legal overhang, investors can focus on the business, which helps the stock.

    The court dismissal eliminates a significant legal risk that had been weighing on Celanese shares.

  • Price hikes on key acetyl products Celanese raised prices on four acetyl products, including acetic acid and vinyl acetate monomer, by up to $0.06 per pound in the US and Canada, with increases elsewhere. Higher prices can boost revenue and profit, especially after its Acetyl Chain sales jumped 28% in the second quarter. This supports the stock.

    The price increases show Celanese's ability to improve pricing, a direct positive for earnings and investor sentiment.

  • New demand from humanoid robot partnership Celanese teamed up with VIGOR Precision to supply high-performance plastics for humanoid robot joints, aiming to cut joint weight by over 30% versus metal. This opens a new market for Celanese's specialty materials, potentially adding future sales and showing growth beyond traditional chemicals.

    The partnership represents a new demand source and innovation, which could drive future revenue growth.

Latest
▲4

Celanese cuts debt, wins legal case, raises prices, adds robot demand

  • Debt reduction via Nutrinova stake sale Celanese is selling another 19% of its Nutrinova food-ingredients venture to Mitsui for about $152 million, cutting its stake to 11%. The cash goes toward paying down debt, part of a plan to raise $1 billion from asset sales by 2027. Lower debt makes the company safer and supports the stock.

    This is a major new step in Celanese's deleveraging plan, directly improving its financial health and reducing risk.

  • Legal claims dismissed in Amsterdam A Dutch court threw out all damages claims against Celanese from Shell and Repsol over past ethylene purchases. This removes a potential financial liability and simplifies the risk picture. With one less legal overhang, investors can focus on the business, which helps the stock.

    The court dismissal eliminates a significant legal risk that had been weighing on Celanese shares.

  • Price hikes on key acetyl products Celanese raised prices on four acetyl products, including acetic acid and vinyl acetate monomer, by up to $0.06 per pound in the US and Canada, with increases elsewhere. Higher prices can boost revenue and profit, especially after its Acetyl Chain sales jumped 28% in the second quarter. This supports the stock.

    The price increases show Celanese's ability to improve pricing, a direct positive for earnings and investor sentiment.

  • New demand from humanoid robot partnership Celanese teamed up with VIGOR Precision to supply high-performance plastics for humanoid robot joints, aiming to cut joint weight by over 30% versus metal. This opens a new market for Celanese's specialty materials, potentially adding future sales and showing growth beyond traditional chemicals.

    The partnership represents a new demand source and innovation, which could drive future revenue growth.

Shin-Etsu Chemical Co., Ltd. (4063.JP)

Q3 2026
▲2▼2

Shin-Etsu: AI demand and photoresist price hikes offset profit miss and China trade hit

  • NVIDIA deepens ties with Japanese suppliers, boosting wafer demand NVIDIA's CEO met with Shin-Etsu and other Japanese suppliers, signaling that AI expansion will keep driving demand for Shin-Etsu's silicon wafers. More AI chips mean more wafer sales, which supports future revenue and profits.

    This is a new demand signal that directly supports Shin-Etsu's core semiconductor materials business.

  • Full-year profit forecast misses market expectations, shares drop 8% Shin-Etsu projected net profit of 525 billion yen, below the 566.8 billion yen analysts expected. The weak outlook, partly from poor vinyl chloride conditions, caused the stock to fall over 8% as investors lowered their expectations.

    This is a new negative event that directly hit the stock price and reflects a real earnings shortfall.

  • Photoresist price hikes of up to 38% lift margins Shin-Etsu and peers are raising photoresist prices by 15% overall from October 1, with high-end grades up to 38% for spot orders. Higher prices should boost Shin-Etsu's revenue and profit margins in this key product line.

    This is a new pricing action that directly improves profitability for a major Shin-Etsu product.

  • China imposes up to 99.2% anti-dumping deposits on Shin-Etsu's dichlorosilane China will require deposits of up to 99.2% on imports of Shin-Etsu's dichlorosilane, a semiconductor material, starting September 8. This trade measure, seen as pressure on Japan, could hurt Shin-Etsu's sales to China and add uncertainty.

    This is a new regulatory/trade action that directly threatens Shin-Etsu's exports and adds a real counterweight.

August 2026
▲2▼2

Shin-Etsu: AI demand and photoresist price hikes offset profit miss and China trade hit

  • NVIDIA deepens ties with Japanese suppliers, boosting wafer demand NVIDIA's CEO met with Shin-Etsu and other Japanese suppliers, signaling that AI expansion will keep driving demand for Shin-Etsu's silicon wafers. More AI chips mean more wafer sales, which supports future revenue and profits.

    This is a new demand signal that directly supports Shin-Etsu's core semiconductor materials business.

  • Full-year profit forecast misses market expectations, shares drop 8% Shin-Etsu projected net profit of 525 billion yen, below the 566.8 billion yen analysts expected. The weak outlook, partly from poor vinyl chloride conditions, caused the stock to fall over 8% as investors lowered their expectations.

    This is a new negative event that directly hit the stock price and reflects a real earnings shortfall.

  • Photoresist price hikes of up to 38% lift margins Shin-Etsu and peers are raising photoresist prices by 15% overall from October 1, with high-end grades up to 38% for spot orders. Higher prices should boost Shin-Etsu's revenue and profit margins in this key product line.

    This is a new pricing action that directly improves profitability for a major Shin-Etsu product.

  • China imposes up to 99.2% anti-dumping deposits on Shin-Etsu's dichlorosilane China will require deposits of up to 99.2% on imports of Shin-Etsu's dichlorosilane, a semiconductor material, starting September 8. This trade measure, seen as pressure on Japan, could hurt Shin-Etsu's sales to China and add uncertainty.

    This is a new regulatory/trade action that directly threatens Shin-Etsu's exports and adds a real counterweight.

Latest
▲2▼2

Shin-Etsu: AI demand and photoresist price hikes offset profit miss and China trade hit

  • NVIDIA deepens ties with Japanese suppliers, boosting wafer demand NVIDIA's CEO met with Shin-Etsu and other Japanese suppliers, signaling that AI expansion will keep driving demand for Shin-Etsu's silicon wafers. More AI chips mean more wafer sales, which supports future revenue and profits.

    This is a new demand signal that directly supports Shin-Etsu's core semiconductor materials business.

  • Full-year profit forecast misses market expectations, shares drop 8% Shin-Etsu projected net profit of 525 billion yen, below the 566.8 billion yen analysts expected. The weak outlook, partly from poor vinyl chloride conditions, caused the stock to fall over 8% as investors lowered their expectations.

    This is a new negative event that directly hit the stock price and reflects a real earnings shortfall.

  • Photoresist price hikes of up to 38% lift margins Shin-Etsu and peers are raising photoresist prices by 15% overall from October 1, with high-end grades up to 38% for spot orders. Higher prices should boost Shin-Etsu's revenue and profit margins in this key product line.

    This is a new pricing action that directly improves profitability for a major Shin-Etsu product.

  • China imposes up to 99.2% anti-dumping deposits on Shin-Etsu's dichlorosilane China will require deposits of up to 99.2% on imports of Shin-Etsu's dichlorosilane, a semiconductor material, starting September 8. This trade measure, seen as pressure on Japan, could hurt Shin-Etsu's sales to China and add uncertainty.

    This is a new regulatory/trade action that directly threatens Shin-Etsu's exports and adds a real counterweight.